Discover the Programme

The scientific programme for the IDF Congress 2022 will feature eight parallel streams that focus on:

  • The basic science and biology of diabetes
  • The development and application of new  therapies and technologies
  • The latest information from clinical trials
  • Prevention of type 2 diabetes
  • Advocacy issues critical to tackling the diabetes pandemic

Click a thumbnail below for a larger version of the preliminary programme schedule for each day of the scientific programme.

Full programme at-a-glance

Message from Programme Chair

On behalf of the Programme Committee, I am proud to invite you to the IDF Congress 2022 in Lisbon.

It is a perfect place for all colleagues from around the world to meet and greet, update scientific knowledge, share new data and innovations and exchange experiences.

The scientific programme of the IDF Congress 2022 will cover a wide range of topics relevant to diabetes. Across eight parallel streams, it will address the basic science and biology of diabetes, the development and application of new drugs, therapies and technologies, the latest information from clinical trials, the burden of diabetes and its complications in populations around the globe, the prevention of diabetes, and policy and advocacy issues critical to tackling the diabetes pandemic.

A particular focus on issues relating to women and the voice of people with diabetes will be a feature of the programme. Speakers will include world-leading experts, early career researchers, and people at the coalface who work with or live with diabetes. A range of different formats from lectures, to debates and workshops will present cutting-edge findings and state-of-the-art reviews. The highly interactive environment will encourage exchanges of views and the development of new ideas and collaborations.

We look forward to welcoming you all to Lisbon for an inspiring and memorable IDF Congress 2022.

Prof. Jonathan Shaw
Chair, Programme Committee

Programme highlights

Dr. Ranjit Mohan Anjana

Applications of big data in diabetes epidemiology

Tuesday, 6 December

Dr. Ranjit Mohan Anjana will discuss using 'big' survey data to get at the heart of the diabetes epidemic in low- and middle-income countries

Manny Hernandez

Peer support in diabetes care

Wednesday, 7 December

Manny Hernandez will discuss the importance of peer support for the diabetes community

Dr Paramesh Shamanna

Debates on hot topics

Wednesday, 7 December

Dr Paramesh Shamanna will discuss whether lifestyle or surgery is the best option for the remission of type 2 diabetes.

Prof Norbert Stefan

Envisioning the future of diabetes management

Thursday, 8 December

Prof Norbert Stefan will discuss non-alcoholic fatty liver disease (NAFLD) as a cause and complication of diabetes.

Dr. Helena Canhão

Novel tactics to address diabetes

Tuesday, 6 December

Dr. Helena Canhão will discuss the relationship between skeletal muscle disorders and diabetes.

Jazz Sethi

The biggest obstacle to change is breaking through the barriers

Wednesday, 7 December

Jazz Sethi will discuss how social perceptions and judgements associated with type 1 diabetes are creating barriers to change.

Dr Tongzhi Wu

Managing type 2 diabetes by exercise and nutritional approaches

Thursday, 8 December

Dr Tongzhi Wu will discuss the implications of taste in the management of type 2 diabetes

Dr Clifford J. Bailey

Oral antidiabetic medications

Thursday, 8 December

Dr Clifford J. Bailey will discuss the role of SGLT2 inhibitors across the cardio-metabolic-renal risk spectrum

Julia Mader

Diabetes technology: Glycemic metrics and outcomes

Tuesday, 6 December

Julia Mader will discuss how CGM is a potent tool to improve and assess glycemic control in primary care networks

Daniela Rojas

Coping with change

Wednesday, 7 December

Daniela Rojas Jiménez will discuss how life transitions can often impact the mental and emotional health of people living with diabetes and their caregivers.

Dr. Ravi Retnakaran

Is GDM a risk factor for CVD?

Thursday, 8 December

Dr. Ravi Retnakaran will make the argument that the diagnosis of gestational diabetes potentially provides a unique opportunity for the primary prevention of cardiovascular disease in women.”

Dr. Jill Norris

Beyond type 1 diabetes

Thursday, 8 December

Dr. Jill Norris will discuss whether the epidemiology of type 1 diabetes changing and why.

Dr. Phyllisa Deroze

Beyond Insulin Pricing

Tuesday, 6 December

Dr. Phyllisa Deroze will share her story of being misdiagnosed, mistreated and receiving incorrect information related to her diabetes.

Dr. Sylvia Kehlenbrink

Diabetes in humanitarian crisis situations

Wednesday, 7 December

Dr. Sylvia Kehlenbrink will discuss the importance of alliances and the past, present and future of the Boston declaration.

Prof Anoop Misra

Diabetes and infection

Thursday, 8 December

Prof Anoop Misra will discuss the co-epidemic of tuberculosis and diabetes in India

Prof Brian Oldenburg

Prevention of type 2 diabetes

Thursday, 8 December

Prof Brian Oldenburg will look at the impact of diabetes prevention trials and highlight the urgent need to develop intervention approaches tailored to local contexts.